GBS Ventures

GBS seeks to lead investments in life science companies which have, or can develop, the following attributes:

a significant Australian presence with assets, employees or activities in Australia

world-leading technology with comprehensive patent protection based on excellent science and with the potential for multiple applications

an experienced management team, or an entrepreneur who will form the nucleus of the management team

significant international market opportunities

a business with a coherent commercialisation plan, rather than a stand-alone project

potential for a high return on investment, and an identifiable exit mechanism, such as a public flotation or trade sale

Particular areas of interest include therapeutic or device opportunities from product focused companies at or near the clinic. We seek to understand the medical need, regulatory challenges and path to registration and reimbursement for new technologies. We are expert at balancing the clinical and regulatory advantages of Australia with major market engagement. GBS has a proven track record of syndicating investments with leading US venture firms when the financing or market opportunities warrant.


Healthtech , MedTech

  • Investor type

    Venture Capital

  • Founded date

    01 January 1996

  • Investment stages

    Series B , Series C

  • Number of exits


  • Investment size


Get in touch